Disruption of the AMPK-TBC 1 D 1 nexus increases lipogenic gene expression and causes obesity in mice via promoting IGF 1 secretion
暂无分享,去创建一个
Hong Yu Wang | C. MacKintosh | K. Sakamoto | H. Wang | Qiaoli Chen | Chao Quan | Bingxian Xie | Liang Chen | Shuilian Zhou | Shuai Chen | Yang Sheng
[1] Hong Yu Wang,et al. Fasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders , 2015, The Journal of Biological Chemistry.
[2] Nolan J. Hoffman,et al. The RabGAP TBC1D1 Plays a Central Role in Exercise-Regulated Glucose Metabolism in Skeletal Muscle , 2015, Diabetes.
[3] Jiahuai Han,et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. , 2014, Cell metabolism.
[4] K. Kaestner,et al. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver , 2014, Nature Communications.
[5] Hong Yu Wang,et al. GARNL1, a major RalGAP α subunit in skeletal muscle, regulates insulin-stimulated RalA activation and GLUT4 trafficking via interaction with 14-3-3 proteins. , 2014, Cellular signalling.
[6] C. Cheung,et al. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010. , 2014, Annals of epidemiology.
[7] B. Neel,et al. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. , 2014, Cell metabolism.
[8] J. Dyck,et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin–sensitizing effects of metformin , 2013, Nature Medicine.
[9] H. Himmelbauer,et al. Conventional knockout of Tbc1d1 in mice impairs insulin- and AICAR-stimulated glucose uptake in skeletal muscle. , 2013, Endocrinology.
[10] A. Schürmann,et al. GTPase ARFRP1 Is Essential for Normal Hepatic Glycogen Storage and Insulin-Like Growth Factor 1 Secretion , 2012, Molecular and Cellular Biology.
[11] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[12] Anne E Carpenter,et al. mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.
[13] D. Wasserman,et al. Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking , 2011, Cell metabolism.
[14] B. Kemp,et al. Whole Body Deletion of AMP-activated Protein Kinase β2 Reduces Muscle AMPK Activity and Exercise Capacity* , 2010, The Journal of Biological Chemistry.
[15] N. Fujii,et al. TBC1D1 Regulates Insulin- and Contraction-Induced Glucose Transport in Mouse Skeletal Muscle , 2010, Diabetes.
[16] Rob C Hoeben,et al. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity , 2008, Nature Genetics.
[17] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[18] Alexandros Tzatsos,et al. Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation , 2006, Molecular and Cellular Biology.
[19] Kei Sakamoto,et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction , 2005, The EMBO journal.
[20] G. Hjälm,et al. The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.
[21] H. Dumon,et al. Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. , 2004, Journal of animal physiology and animal nutrition.
[22] David Carling,et al. Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .
[23] Jérôme Boudeau,et al. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.
[24] B. Spiegelman,et al. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. , 2003, The Journal of clinical investigation.
[25] B. Viollet,et al. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. , 2004, The Journal of biological chemistry.